Deep knowledge of genomic technologies for precision healthcare, with special emphasis on next-generation sequencing, and the application across drug discovery, drug development and into the marketplace. Special emphasis on pharmacogenomics applied to the use of human genetics to inform relevance of targets for human disease and to better inform clinical outcomes.

Co-founder, senior officer, or Board appointed consultant for 7 healthcare analytics companies over the past 18 years, including two exits. Deep experience in creating and implementing successful Go to Market strategies and collaborations that rapidly scale businesses from raw 'products' to commercially viable operating entities based on strong core value propositions for healthcare provider, payer, and analytics platform customers.